Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation

Author： Tranguch Susanne Smith David F Dey Sudhansu K

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.13, Iss.5, 2006-11, pp. : 651-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease

Current Molecular Pharmacology, Vol. 9, Iss. 2, 2015-12 ,pp. : 109-125

Bentham Science Publishers

Access to resources Recommend Favorite

Progesterone antagonists and progesterone receptor modulators

By Spitz Irving M

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1693-1707

Informa Healthcare

Access to resources Recommend Favorite

Progesterone receptor agonists and antagonists

By Allan G. Macielag M.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. : 955-962

Informa Healthcare

Access to resources Recommend Favorite

Signalling without the receptor

By Wood I.

Trends in Pharmacological Sciences, Vol. 21, Iss. 10, 2000-10 ,pp. : 371-371

Elsevier

Access to resources Recommend Favorite

Non-steroidal progesterone receptor modulators

By Zhang Puwen Fensome Andrew Wrobel Jay Winneker Richard Zhang Zhiming

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 12, 2003-12 ,pp. : 1839-1847

Informa Healthcare

Access to resources Recommend Favorite